Semaglutide is typically a weight loss medication given to people with moderate to severe obesity to support weight loss. It is often used before weight loss surgery is considered to help minimize the need for surgery. However, there are some studies that are now indicative that the use of semaglutide after bariatric surgery can be a good option.
In People Who Need More Help
Some of the most interesting studies about semaglutide use after bariatric surgery show that adults who did not respond well enough or at all to bariatric surgery will have success with the use of this medication. The studies found that the use of a one-time-a-week semaglutide treatment could help those who did not respond initially to bariatric surgery achieve 9.8% weight loss over the course of 24 weeks. A 10% or higher weight loss was achieved by as many as 36% of patients who attempted the study who had bariatric surgery.
Diabetes Support
Another study found that the use of semaglutide in patients after bariatric surgery who continued to struggle with Type 2 diabetes could see significant improvement. The use of the medication helped patients three months and six months after their initial weight loss surgery to increase their rate of loss by controlling type 2 diabetes more effectively. This could help to improve health outcomes while also stimulating additional weight loss in patients.
The results of these studies are not comprehensive, and not everyone will have the same benefits. However, researchers continue to study the benefits of Semaglutide use after bariatric surgery to support the success of patients on a lifelong journey to lose weight. However, it’s important to note that not all people who have weight loss surgery will qualify for the use of semaglutide, depending on their health and other risk factors they have.
To view more Frequently Asked Questions, click here.
